Rossari Biotech Limited has informed the Exchange regarding a press release dated April 25, 2025, titled "Rossari Biotech announces Q4 & FY25 results".
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rossari Biotech Limited has filed an intimation with the NSE regarding a press release dated April 25, 2025, announcing its financial results for the fourth quarter (Q4) and full financial year ending March 2025 (FY25). This is a standard regulatory disclosure informing the exchange that the company has formally released its quarterly and annual earnings update to the public. The detailed financial numbers, including revenue, profit, margins, and segment performance, would be contained in the attached press release document.
This is a routine earnings announcement filing. The actual stock reaction will depend on how the FY25 numbers and Q4 performance compare with market expectations and year-ago figures, which would be detailed in the full press release.